The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2015

Filed:

Nov. 21, 2011
Applicants:

Takayuki Asahara, Arlington, MA (US);

Douglas W. Losordo, Chicago, IL (US);

Linda Isner, Weston, MA (US);

Inventors:

Jeffrey M. Isner, Weston, MA (US);

Takayuki Asahara, Arlington, MA (US);

Douglas W. Losordo, Chicago, IL (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/28 (2006.01); A61K 35/44 (2006.01); A61K 45/06 (2006.01); C12N 5/071 (2010.01); G01N 33/569 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 35/44 (2013.01); A61K 45/06 (2013.01); C12N 5/0692 (2013.01); G01N 33/56966 (2013.01); A61K 2035/124 (2013.01);
Abstract

In accordance with the present invention, EC progenitors can be used in a method for regulating angiogenesis, i.e., enhancing or inhibiting blood vessel formation, in a selected patient and in some preferred embodiments for targeting specific locations. For example, the EC progenitors can be used to enhance angiogenesis or to deliver an angiogenesis modulator, e.g. anti- or pro-angiogenic agents, respectively to sites of pathologic or utilitarian angiogenesis. Additionally, in another embodiment, EC progenitors can be used to induce reendothelialization of an injured blood vessel, and thus reduce restenosis by indirectly inhibiting smooth muscle cell proliferation.


Find Patent Forward Citations

Loading…